We have located links that may give you full text access.
Clinical Trial
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Phototherapeutic keratectomy for map-dot-fingerprint corneal dystrophy.
Cornea 1998 November
PURPOSE: To evaluate the excimer laser as a surgical instrument to treat map-dot-fingerprint (MDF) dystrophies.
METHODS: Thirty eyes (24 patients) with MDF dystrophy were treated with phototherapeutic keratectomy (PTK). The treatment goal was either to improve vision (24 eyes) or to heal recurrent corneal erosions or both (10 eyes). Besides long-standing reduction in visual acuity (17 eyes), associated symptoms were fluctuating visual acuity and clinical refraction (12 eyes) and monocular diplopia (eight eyes). In 14 eyes, two or three symptoms were present, whereas 16 eyes only had one symptom. The mean age was 54 years (range, 36-79 years), and there were 14 male and 10 female subjects. Mean follow-up was 30 months (range, 12-70 months).
RESULTS: In 14 of 17 eyes with long-standing reduction in visual acuity, best spectacle-corrected Snellen visual acuity (BSCVA) improved by two lines or more. All eyes with fluctuating visual acuity/clinical refraction stabilized 1-3 months after PTK. Monocular diplopia or "ghost images" disappeared in all eyes after treatment. In one of 10 eyes with recurrent corneal erosions, there was one recurrence during the follow-up period. All eyes healed shortly after treatment. No recurrence of corneal dystrophic changes was seen in the ablation zone at the final follow-up (mean, 30 months). Dystrophic changes could, however, still be seen outside the treatment zone in 50% of the eyes, but were asymptomatic in all eyes. The mean refractive change was 0.34 +/- 1.05 (mean +/- SD) diopters.
CONCLUSION: In this study, excimer laser photoablation was shown to be an effective, safe, and stable choice of treatment for map-dot-fingerprint dystrophy. A refractive change, as hyperopic shift, can be an adverse side effect in some individual cases.
METHODS: Thirty eyes (24 patients) with MDF dystrophy were treated with phototherapeutic keratectomy (PTK). The treatment goal was either to improve vision (24 eyes) or to heal recurrent corneal erosions or both (10 eyes). Besides long-standing reduction in visual acuity (17 eyes), associated symptoms were fluctuating visual acuity and clinical refraction (12 eyes) and monocular diplopia (eight eyes). In 14 eyes, two or three symptoms were present, whereas 16 eyes only had one symptom. The mean age was 54 years (range, 36-79 years), and there were 14 male and 10 female subjects. Mean follow-up was 30 months (range, 12-70 months).
RESULTS: In 14 of 17 eyes with long-standing reduction in visual acuity, best spectacle-corrected Snellen visual acuity (BSCVA) improved by two lines or more. All eyes with fluctuating visual acuity/clinical refraction stabilized 1-3 months after PTK. Monocular diplopia or "ghost images" disappeared in all eyes after treatment. In one of 10 eyes with recurrent corneal erosions, there was one recurrence during the follow-up period. All eyes healed shortly after treatment. No recurrence of corneal dystrophic changes was seen in the ablation zone at the final follow-up (mean, 30 months). Dystrophic changes could, however, still be seen outside the treatment zone in 50% of the eyes, but were asymptomatic in all eyes. The mean refractive change was 0.34 +/- 1.05 (mean +/- SD) diopters.
CONCLUSION: In this study, excimer laser photoablation was shown to be an effective, safe, and stable choice of treatment for map-dot-fingerprint dystrophy. A refractive change, as hyperopic shift, can be an adverse side effect in some individual cases.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app